We are live on ! Find out more
SC

Searle & Co Portfolio holdings

AUM $398M
1-Year Est. Return 22.87%
This Fund
S&P 500
This Quarter Est. Return
+19.63%
1 Year Est. Return
+22.87%
3 Year Est. Return
+66.45%
5 Year Est. Return
+103%
10 Year Est. Return
+295.26%
AUM
$172M
AUM Growth
+$31.4M
Cap. Flow
+$6.81M
Cap. Flow %
3.95%
Top 10 Hldgs %
31.07%
Holding
144
New
12
Increased
10
Reduced
22
Closed
4

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$4.52M
2
NKE icon
Nike
NKE
+$1.55M
3
IRM icon
Iron Mountain
IRM
+$1.14M
4
AMZN icon
Amazon
AMZN
+$725K
5
ABBV icon
AbbVie
ABBV
+$337K

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$1.61M
2
AGO icon
Assured Guaranty
AGO
+$1.43M
3
CLF icon
Cleveland-Cliffs
CLF
+$199K
4
AYTU icon
AYTU BioPharma
AYTU
+$199K
5
TBT icon
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
+$166K

Sector Composition

Rank Sector Weight
1 Healthcare 21.93%
2 Technology 18.94%
3 Industrials 10.96%
4 Financials 10.71%
5 Consumer Discretionary 9.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMO icon
126
Imperial Oil
IMO
$59.2B
$161K 0.09%
10,000
– –
BDSI
127
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$153K 0.09%
35,000
-15,000
-30% -$67.4K
XERS icon
128
Xeris Biopharma Holdings
XERS
$1.52B
$148K 0.09%
69,000
+17,000
+33% +$59.2K
HAL icon
129
Halliburton
HAL
$29.4B
$133K 0.08%
10,249
– –
ET icon
130
Energy Transfer Partners
ET
$69.9B
$85K 0.05%
12,000
-812
-6% -$6.02K
KYN icon
131
Kayne Anderson Energy Infrastructure Fund
KYN
$2.47B
$63K 0.04%
12,000
– –
LYG icon
132
Lloyds Banking Group
LYG
$86.6B
$60K 0.03%
40,000
– –
NUWE icon
133
Nuwellis
NUWE
$263K
– –
0
– –
ACHV icon
134
Achieve Life Sciences
ACHV
$644M
$45K 0.03%
5,655
– –
NGL icon
135
NGL Energy Partners
NGL
$1.89B
$39K 0.02%
10,000
– –
AYTU icon
136
AYTU BioPharma
AYTU
$23.1M
$36K 0.02%
125
-656
-84% -$199K
GMLP
137
DELISTED
Golar LNG Partners LP
GMLP
$32K 0.02%
12,500
– –
GPOR
138
DELISTED
Gulfport Energy Corp.
GPOR
$20K 0.01%
18,500
– –
VGZ icon
139
Vista Gold
VGZ
$225M
$8K ﹤0.01%
10,000
– –
VAL
140
DELISTED
Valaris plc Class A Ordinary Share
VAL
$7K ﹤0.01%
10,000
– –
AGO icon
141
Assured Guaranty
AGO
$3.76B
– –
-55,350
Closed -$1.43M
CLF icon
142
Cleveland-Cliffs
CLF
$5.29B
– –
-50,500
Closed -$199K
TBT icon
143
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$289M
– –
-10,350
Closed -$166K
AGN
144
DELISTED
Allergan plc
AGN
– –
-9,105
Closed -$1.61M
2 3 4 5
6

Similar funds

CF
Cypress Funds Los Angeles, California $398M AUM 8.77% 1-Year Est. Return
VC
Vision Capital Toronto, Ontario, Canada $397M AUM 0.8% 1-Year Est. Return
DL
Dockside LLC New York $397M AUM
ECA
Elevated Capital Advisors Sandy, Utah $397M AUM 11.67% 1-Year Est. Return
BWM
BCGM Wealth Management Lafayette, Indiana $398M AUM 17.85% 1-Year Est. Return
MHC
May Hill Capital Cohasset, Massachusetts $398M AUM 23.9% 1-Year Est. Return
LSA
Lansing Street Advisors Ambler, Pennsylvania $397M AUM 18.7% 1-Year Est. Return
THL
Tillman Hartley LLC Denver, Colorado $398M AUM 16.44% 1-Year Est. Return

Searle & Co's Q2 2020 Portfolio in Review

As of Q2 2020, Searle & Co held 144 positions worth $172M, up 22% from $141M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Searle & Co deployed $6.81M of net new capital in Q2 2020, opening 12 new positions and adding to 10 existing holdings. Its largest new stake was Nike: 16,795 shares worth $1.65M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 25% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was AYTU BioPharma, an estimated $199K trimmed.

  • Searle & Co's largest Q2 2020 buy was Nike: 16,795 shares worth $1.65M.
  • Searle & Co added most to Apple in Q2 2020, an estimated $4.52M increase.
  • Searle & Co's biggest Q2 2020 reduction was AYTU BioPharma, cutting an estimated $199K.
  • Searle & Co fully exited Allergan plc in Q2 2020, selling an estimated $1.61M.
  • Searle & Co's ten largest holdings make up 31% of its $172M portfolio in Q2 2020.
  • Searle & Co opened 12 new positions and closed 4 in Q2 2020.
  • Searle & Co's portfolio value rose 22% quarter-over-quarter to $172M.

Based on Searle & Co's 13F filing for Q2 2020, filed 3 Aug 2020.